Status:
RECRUITING
A Comprehensive Registry Study of the Whole Life Cycle of Patients With CHD
Lead Sponsor:
Beijing Anzhen Hospital
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
Brief Summary
This observational study aims to collect data on the prevalence, intervention, and prognosis of congenital heart disease (CHD) in Chinese patients across their entire lifecycle. From the diagnosis of ...
Eligibility Criteria
Inclusion
- Patients with various congenital heart diseases
Exclusion
- None
Key Trial Info
Start Date :
February 2 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2030
Estimated Enrollment :
100000 Patients enrolled
Trial Details
Trial ID
NCT06611787
Start Date
February 2 2024
End Date
January 1 2030
Last Update
September 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing AnZhen Hospital
Beijing, Beijing Municipality, China, 100000